{"name":"Hasten Biopharmaceutical Co., Ltd.","slug":"hasten-biopharmaceutical-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Levoamlodipine Maleate Table","genericName":"Levoamlodipine Maleate Table","slug":"levoamlodipine-maleate-table","indication":"Hypertension","status":"phase_2"}]}],"pipeline":[{"name":"Levoamlodipine Maleate Table","genericName":"Levoamlodipine Maleate Table","slug":"levoamlodipine-maleate-table","phase":"phase_2","mechanism":"Calcium channel blocker","indications":["Hypertension"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxNWjAwdm9jbGl5dE5VU2VLdWtWOWNLTXlWbTBwdmZrM2VvTEE3TUZmbmtVWGlnM2VEOFFwRkJZbkRfZ2s0Y1FTS1FOSW9SbmZnZ3psd09iX20tMGZoRWRqYWlsSXdaWGtuenYxWUM3OTZSMmVFTFBJWlp3NmtjbGdPWGpfRkxvbmQydmdXcnpTVFhCUXpMUUd5Q3FKaV9jNm5ib1g4MndyLWUzV3dKdU5TY0ppVk9rLWFwV1VxRURmTlp6LTdTdm5vTFhkaENEQ1ozeWF3?oc=5","date":"2026-04-08","type":"deal","source":"BioPharma APAC","summary":"Everest Medicines To Acquire Hasten Biopharmaceuticals Singapore Unit In USD 250 Million Deal - BioPharma APAC","headline":"Everest Medicines To Acquire Hasten Biopharmaceuticals Singapore Unit In USD 250 Million Deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgJBVV95cUxPRUljUU03b2pwYUhBOG9UM3BRYmhac2FOdEhnYWtiTVVDNkpZT2VEb1BUVWQxdVU2WFRrdVpPXzFUb21uVEJMWldCVkJxRWlxbWZSQ2ZZbXZoMEE0cV8wdlVfM2lNVk05QUd3RlE4WFVaLTBoakpVSWF0eHlFSmlWOExRWEZHUDBIaF9oa0dmaUYwdGxvSE80cnBkUmVtenhJMmlidTducWtQUDlxbTJfZGVHTF9WVGsyZlJaczJ6NjNVekVUUm0yOUZsWTE0Q1l5UFl5MjVsLTlqTWs4N0V0ZEl3ODJTTmZVZkd6Z3k2TEFWT1AtY3NCOEZicXZ0OWFwSnNuYnZ3WkQyRVNnNFVhQkpR?oc=5","date":"2026-03-31","type":"pipeline","source":"BioSpace","summary":"LIB Therapeutics Announces Results from Presentations on LEROCHOL® at 2026 American College of Cardiology meeting in New Orleans March 28-29, 2026 - BioSpace","headline":"LIB Therapeutics Announces Results from Presentations on LEROCHOL® at 2026 American College of Cardiology meeting in New","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-18","type":"pipeline","source":"The Manila Times","summary":"Everest Medicines Enters into Letter of Intent with Hasten Biopharmaceuticals (Asia) Limited - The Manila Times","headline":"Everest Medicines Enters into Letter of Intent with Hasten Biopharmaceuticals (Asia) Limited","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxNRlZiYVBhNG5kWkZnUm9hVUxZWFNybnBCSXZ5M2J0bllWT3VwZmpFYktlOU1QRFc4YWJ6SG9UWXBQbTlNZzFmMW44WDBqcWc2cmgxV1AwT1ZmLUFteS1GbHFibUhZWVdkeFNva09uX3JBSUswT2ZXSFM4eF9tZWZVRkk2dmMzdDBSX0o1N1hnaEs1QVhqRS1TUk81UVgxeGNUQlg3Ykx1QzNjVjZ0TXg0RlZscmc4NmFMRGttTkpfaTJBMHJhMjZyeGhVc1M?oc=5","date":"2025-12-15","type":"pipeline","source":"BioPharma APAC","summary":"Everest Medicines Enters Dual Strategic Agreements with Hasten to Drive Accretive Growth - BioPharma APAC","headline":"Everest Medicines Enters Dual Strategic Agreements with Hasten to Drive Accretive Growth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwJBVV95cUxOcnBOOHI1dlJfamNtNXdCLUo3Ynl2S1R2RGx3N3BlNEp2SG9oeVI5OVdTYXdOVF9oTC1wUzNZSnZmRTQxajJ4eG5YNWk2TlhLajhXUDk3a3NxNU85UnBjYTVWdXhTbzcxSzZvZ1dlazdOREpTQ0lDY3BpY20zMFktc1pCTnVqWnRrZkcyS21EenZQTFdWYTJLSzR5ZklGU2poNERYYm54SnNWRTNTd3E4VmVJUVdvS1doc01SQUxkc2xiNS1KYmE1WllqQlZ2ZzE2Z1lkMmhaQVdfRldlSmhoTkdVNDd1Y1oxRThCSElOSDlGNGlZVDJSQllyQjdVTTN1SEFKZzZ1eXdFZ2M?oc=5","date":"2025-11-04","type":"pipeline","source":"PR Newswire","summary":"Hasten Sets a New Benchmark for Global Expansion‌ by Building an End-to-End Asia-Pacific Healthcare Commercial Platform - PR Newswire","headline":"Hasten Sets a New Benchmark for Global Expansion‌ by Building an End-to-End Asia-Pacific Healthcare Commercial Platform","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxNM19HZjVNRzQySXV4cVBOY1J4SWNRak41R3dhem81NkpkV0NBZzJQRHROZ2RuVmRwcEVsS09iZlctZW56YjFnUUxCVlJfNEt0ODhHbHZIdGM4eVA0YWV5S2NNcEZmVDNGU0hua293MFJJUEtYNFZnMUJ1d1l4OERVV1dCMjhkYTZuVGtxeFBYX0VkUG9YOHBfaHdfaw?oc=5","date":"2024-09-10","type":"deal","source":"Generics and Biosimilars Initiative","summary":"China’s Hasten Biopharma acquires 14 products from Celltrion - Generics and Biosimilars Initiative","headline":"China’s Hasten Biopharma acquires 14 products from Celltrion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxPX2NKRkV0SDl0aWpkaHREaTZncHlFaG9Qc2RuelpudXlnSnZZUi1tRjNsYTJpczZJNWl3ZXp1c3RSa2NDbExUMjFZZ2ZoWjFMSENlRjVjRlAxbnJSQ1ppamY2MTZCdHF1UkdZOFBlMFhBZ2g5VkQwaFRPaUt6RVlFc3QwUjBMUWVZT3BYY2I5OXhzRTlPVDJSWmpOanA0Vk4ySHA4RzRJRHFvOEIzZ2ljWlpzaDZPQ1M1ZlRtMFc0ZHpyLVlZMkdz?oc=5","date":"2024-07-02","type":"deal","source":"BioSpectrum Asia","summary":"Chinese startup Hasten Biopharma buys 14 products from Korean firm Celltrion - BioSpectrum Asia","headline":"Chinese startup Hasten Biopharma buys 14 products from Korean firm Celltrion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxQTVFGQVY1bU5qOFhnNENxOU5ycUJYVlBLZ19PdjVpOFRnNlpzVTY1dzVFOHdmMzc5b0JROTVleHNlaTBHQmt6OEc0SFBKalIxcEFsRWJBX0dFZm53RTJtZUFnZ3pCb28wXzV0QldYck4xNk5mTGJmNFhqUGduakFGQmxKYW1kMmlnU2tab3pEamszTUJZQ3N5UEg2eHI1SGg2ZThBd19n?oc=5","date":"2024-07-01","type":"deal","source":"worldpharmaceuticals.net","summary":"Hasten Biopharmaceutical acquires 14 products from Celltrion - worldpharmaceuticals.net","headline":"Hasten Biopharmaceutical acquires 14 products from Celltrion","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxOaG5oYmUxOXdlRFRRQXMydEc0emVSWXhMUV9CSmJmMUdMUkVKSElaZjlOQmRVeXBOU1lia3huTl90d2wtS2lVSVpYb0Z2eWdoSG5Mb2hDbURrOUFiTFRjMmlvNnFaSGFRazZOekVvb1c0ck5sMnJLYWZ4dHhaMFVVYW9qWU5HTGNZU194S0wtaw?oc=5","date":"2024-05-29","type":"pipeline","source":"drugdiscoverytrends.com","summary":"100 of the best-funded private healthcare and biotech companies - drugdiscoverytrends.com","headline":"100 of the best-funded private healthcare and biotech companies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgJBVV95cUxPb0FZTjZma3F6SVZKSHR6NXVEZkhGWG5ibTY5QmRvbjVROURLWGprbFdmRVQtdFQ1bXV0MzgwWnJsMGVmNnZtTUhKcEpOSXk1ZTQ3Ny1rZjBDOXBEeEpmSjFSZFNub2pfS2xUTlREVUd4LU9ESzlSeFMwdWZCcElSVVprZGpvRE03OTdKWWlzZjdsaTJVWl9Md1BuMWZhQ29oNlg1eVlLaFhOSXo0Y2o5QmI2d3dHTHh6X0ZMdk1TTDZwRjlpTklNekZuUUJWUkVxMmMxLWxnWnlTcXRES3ZjMldybU96MFdJeVctTEI2cThKd3FocDZnU1VpSUtLeng5Z2NQUHZWQy1URjZDTGIxUElDSTRIVy0zcnNhZGdSN1RWMnBYSXZJcmJFT3ZLd3BqM0JfUjItakpGOVpjMlE?oc=5","date":"2023-09-12","type":"deal","source":"businesswire.com","summary":"LIB Therapeutics and Hasten Biopharmaceutical Company Announce $325 Million Strategic Collaboration to Develop and Commercialize Lerodalcibep in Greater China - businesswire.com","headline":"LIB Therapeutics and Hasten Biopharmaceutical Company Announce $325 Million Strategic Collaboration to Develop and Comme","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxPWmJpaG82cEVoV25FYy05WkcwLXVRZ2VRRFExWHVXbU9PRk55Q3pmWTRuWXlnYS1XQVc5RkJYV1VkLUlramFueGo2OFNka1I0dHRCb2dxSXlRQnRaNWhGdHBDM2pQUnNxY3VWNGZfU3U2ckczQVZHdjBWQjNqNjZZUnNrYmZ1V1JtcTdGNTFnb1FDRHV6NDQ0LVBPWXhtMGVQWEh0U0JxWUtmWDhXYlczb19PV2huZ3ZlblE?oc=5","date":"2023-09-12","type":"pipeline","source":"Fierce Biotech","summary":"Exelixis links up with AI drug finder Insilico, LIB offloads China rights for PCSK9 inhibitor - Fierce Biotech","headline":"Exelixis links up with AI drug finder Insilico, LIB offloads China rights for PCSK9 inhibitor","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxPNlo0SE82Vk1nVjFadWhnaThERWlsVW5nWlVwUHBLTTdJYXBfZ0N0cnlNY21hVUxQYjluZE5aa3Z6cGVYb0xCUE9TNHp5dElxUHRBMFVGNUMyOTctTWFhck1TZ2hTVkNBNDVXTnBEZ1dDUGhQaGFERzRWOFhtWGhEeXRWZTc5TDZpcE83b0JkOVhsUEhLejNOcWt0Z1RLeUE?oc=5","date":"2023-04-20","type":"pipeline","source":"Pharmaceutical Technology","summary":"Hasten Biopharmaceutic raises $315m for pipeline assets development - Pharmaceutical Technology","headline":"Hasten Biopharmaceutic raises $315m for pipeline assets development","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}